ICD-10-CM Code C67.9

Malignant neoplasm of bladder, unspecified

Version 2020 Billable Code Neoplasm Malignant Primary

Valid for Submission

C67.9 is a billable code used to specify a medical diagnosis of malignant neoplasm of bladder, unspecified. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C67.9 might also be used to specify conditions or terms like adenocarcinoma of bladder, carcinoma of bladder, carcinoma of urinary bladder, invasive, carcinoma of urinary bladder, superficial, local recurrence of malignant tumor of urinary bladder, malignant neoplasm of augmented bladder, etc

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: bladder (urinary) or bladder (urinary) orifice or bladder (urinary) wall .

ICD-10:	C67.9
Short Description:	Malignant neoplasm of bladder, unspecified
Long Description:	Malignant neoplasm of bladder, unspecified

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Adenocarcinoma of bladder
Carcinoma of bladder
Carcinoma of urinary bladder, invasive
Carcinoma of urinary bladder, superficial
Local recurrence of malignant tumor of urinary bladder
Malignant neoplasm of augmented bladder
Malignant tumor involving an organ by direct extension from bladder
Malignant tumor involving an organ by separate metastasis from bladder
Malignant tumor involving prostate by direct extension from bladder
Malignant tumor involving prostate by separate metastasis from bladder
Malignant tumor involving seminal vesicle by direct extension from bladder
Malignant tumor involving seminal vesicle by separate metastasis from bladder
Malignant tumor involving ureter by direct extension from bladder
Malignant tumor involving ureter by separate metastasis from bladder
Malignant tumor involving urethra by direct extension from bladder
Malignant tumor involving urethra by separate metastasis from bladder
Malignant tumor involving uterine corpus by direct extension from bladder
Malignant tumor involving uterine corpus by separate metastasis from bladder
Malignant tumor involving vagina by direct extension from bladder
Malignant tumor involving vagina by separate metastasis from bladder
Malignant tumor of seminal vesicle
Malignant tumor of seminal vesicle
Malignant tumor of urinary bladder
Metastasis from malignant tumor of bladder
Obstructive nephropathy due to bladder cancer
Obstructive nephropathy due to malignancy
pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension
pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension
pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension
Primary malignant neoplasm of bladder
Primary spindle cell carcinoma of urinary bladder
pT1: Tumor invades subepithelial connective tissue
pT2: Tumor invades muscularis propria
pT2a: Tumor invades superficial muscle
pT2b: Tumor invades deep muscle
pT3: Tumor invades perivesical tissue
pT3a: Tumor invades perivesical tissue microscopically
pT3b: Tumor invades perivesical tissue macroscopically
pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall
pT4a: Tumor invades prostate or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
pTa: Non-invasive papillary carcinoma
Rhabdomyosarcoma of bladder
Sarcoma of bladder
Secondary malignant neoplasm of prostate
Secondary malignant neoplasm of seminal vesicle
Secondary malignant neoplasm of ureter
Secondary malignant neoplasm of urethra
Secondary malignant neoplasm of vagina
Squamous cell carcinoma of bladder
T2: Urinary bladder tumor invades muscle
T2a: Urinary bladder tumor invades superficial muscle
T2b: Urinary bladder tumor invades deep muscle
T3: Urinary bladder tumor invades perivesical tissue
T3a: Bladder tumor invades perivesical tissue microscopically
T3b: Bladder tumor invades perivesical tissue macroscopically
T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall
T4a: Bladder tumor invades prostate or uterus or vagina
T4b: Bladder tumor invades pelvic wall or abdominal wall
Transitional cell carcinoma of bladder
Tumor of seminal vesicle
Tumor of seminal vesicle

Diagnostic Related Groups

The ICD-10 code C67.9 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2020.

656 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC
657 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC
658 - KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC

Convert C67.9 to ICD-9

188.9 - Malig neo bladder NOS

Code Classification

Neoplasms (C00–D48)
- Malignant neoplasms of urinary tract (C64-C68)
  - Malignant neoplasm of bladder (C67)

Code History

FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set)
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C67.9 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic	Malignant Primary	Malignant Secondary	CaInSitu	Benign	Uncertain Behavior	Unspecified Behavior
»bladder (urinary)	C67.9	C79.11	D09.0	D30.3	D41.4	D49.4
»bladder (urinary) »orifice	C67.9	C79.11	D09.0	D30.3	D41.4	D49.4
»bladder (urinary) »wall	C67.9	C79.11	D09.0	D30.3	D41.4	D49.4

Information for Patients

Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

Blood in your urine
A frequent urge to urinate
Pain when you urinate
Low back pain

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute

[Learn More]

Bladder cancer Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply without control or order. The bladder is a hollow, muscular organ in the lower abdomen that stores urine until it is ready to be excreted from the body. The most common type of bladder cancer begins in cells lining the inside of the bladder and is called transitional cell carcinoma (TCC).Bladder cancer may cause blood in the urine, pain during urination, frequent urination, or the feeling that one needs to urinate without results. These signs and symptoms are not specific to bladder cancer, however. They also can be caused by noncancerous conditions such as infections.
[Learn More]

Previous Code: C67.8

Related Codes

Next Code: C68